The global self-administered parenteral market is on an impressive growth trajectory, poised to reach a remarkable USD 25,339.7 million by 2024, as highlighted by recent industry analysis. This upward trend is expected to continue, with a robust compound annual growth rate (CAGR) of 4.8% projected over the next decade. By 2034, the market is anticipated …